These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14238598)

  • 1. [THE BEHAVIOR OF LIVER GLYCOGEN IN DIABETES IN AGED SUBJECTS UNDER THE INFLUENCE OF INSULIN AND THE ORAL ANTIDIABETIC 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PY RIMIDINE (GLYCODIAZIN)].
    BERINGER A; THALER H
    Arzneimittelforschung; 1964 May; 14():403-4. PubMed ID: 14238598
    [No Abstract]   [Full Text] [Related]  

  • 2. [REPORT ON THE CLINICAL TESTING OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].
    LEUBNER H
    Arzneimittelforschung; 1964 May; 14():404-6. PubMed ID: 14238599
    [No Abstract]   [Full Text] [Related]  

  • 3. [PHARMACOLOGY OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING COMPOUND].
    KRAMER M; HECHT G; LANGECKER H; HARWART A; RICHTER KD; GLOXHUBER C
    Arzneimittelforschung; 1964 May; 14():377-85. PubMed ID: 14238594
    [No Abstract]   [Full Text] [Related]  

  • 4. [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].
    GUTSCHE H; BOENICKE G
    Arzneimittelforschung; 1964 May; 14():409-11. PubMed ID: 14238601
    [No Abstract]   [Full Text] [Related]  

  • 5. [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING AGENT. I. THE METABOLISM OF GLYCODIAZIN IN MAN].
    GERHARDS E; GIBIAN H; KOLB KH
    Arzneimittelforschung; 1964 May; 14():394-402. PubMed ID: 14238597
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN). EXPERIENCES WITH 160 DIABETICS].
    ROBBERS H; BRUMBY KH; TRAUMANN KJ
    Arzneimittelforschung; 1964 May; 14():406-9. PubMed ID: 14238600
    [No Abstract]   [Full Text] [Related]  

  • 7. [ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)].
    BERNHARD H
    Arzneimittelforschung; 1964 May; 14():411-2. PubMed ID: 14238602
    [No Abstract]   [Full Text] [Related]  

  • 8. [MECHANISM OF ACTION OF HYPOGLYCEMIC SUBSTANCES].
    HIRSCH C
    Prod Probl Pharm; 1963 Sep; 18():419-27. PubMed ID: 14093261
    [No Abstract]   [Full Text] [Related]  

  • 9. [RESORPTION, DISTRIBUTION AND EXCRETION OF RADIOACTIVE-LABELLED 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN ANIMAL EXPERIMENTS].
    KOLB KH; KRAMER M; SCHULZE PE
    Arzneimittelforschung; 1964 May; 14():385-9. PubMed ID: 14238595
    [No Abstract]   [Full Text] [Related]  

  • 10. [FOR A NEW TREND IN PHARMACOLOGICAL RESEARCH ON THE EFFECTS OF SULFONAMIDES IN LATE BENIGN DIABETES].
    WAHL M
    Diabete; 1964; 12():135-7. PubMed ID: 14180588
    [No Abstract]   [Full Text] [Related]  

  • 11. [SULFONAMIDOPYRIMIDINES, A NEW GROUP OF BLOOD SUGAR-LOWERING COMPOUNDS].
    GUTSCHE K; HARWART A; HORSTMANN H; PRIEWE H; RASPE G; SCHRAUFSTAETTER E; WIRTZ S; WOERFFEL U
    Arzneimittelforschung; 1964 May; 14():373-6. PubMed ID: 14238593
    [No Abstract]   [Full Text] [Related]  

  • 12. [TOLERANCE OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN LONG-TERM ADMINISTRATION IN ANIMAL EXPERIMENTS].
    KRAMER M; HECHT G; GUENZEL P; HARWART A; RICHTER KD; GLOXHUBER C
    Arzneimittelforschung; 1964 May; 14():389-94. PubMed ID: 14238596
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the antidiabetic action of hypoglycemic sulfonamides. Basis of their utilization for determining the lasting remission or the prevention of diabetes].
    LOUBATIERES A
    Presse Med (1893); 1960 Sep; 68():1441-4. PubMed ID: 13763660
    [No Abstract]   [Full Text] [Related]  

  • 14. The oral antidiabetic compounds; selection of patients by means of a blood sugar response test.
    WELLER C
    N Y State J Med; 1956 Nov; 56(21):3333-7. PubMed ID: 13369787
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON QUANTITATIVE STUDIES OF THE GLYCOGEN CONTENT OF THE LIVER IN HEALTHY AND DISEASED SUBJECTS. 3. ACTION MECHANISM OF GLUCAGON].
    BERINGER A; THALER H
    Wien Med Wochenschr; 1965 Feb; 115():105-7. PubMed ID: 14260959
    [No Abstract]   [Full Text] [Related]  

  • 16. [On 2-benzolsulfonylamine-5(beta-methoxyethoxy)-pyrimidine (Glycodiazine). VI. Experiments on the mechanism of action of the oral antidiabetic Glycodiazine in healthy test persons].
    Gerhards E; Nieuweboer B; Gutsche H
    Arzneimittelforschung; 1968 May; 18(5):570-7. PubMed ID: 5756198
    [No Abstract]   [Full Text] [Related]  

  • 17. [RESPECTIVE ACTIONS OF 3 HYPOGLYCEMIC THIADIAZOLOSULFONAMIDES ON THE BLOOD SUGAR OF THE NONANESTHETIZED DOG].
    LOUBATIERES A; MARIANI MM; ALRIC R; CHAPAL J
    C R Seances Soc Biol Fil; 1964; 158():610-2. PubMed ID: 14193731
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action of hypoglycemic sulfonamides: action of p-aminobenzoic acid on the blood sugar].
    ZAGURY D; GHATA J
    C R Hebd Seances Acad Sci; 1961 Mar; 252():2010-1. PubMed ID: 13787648
    [No Abstract]   [Full Text] [Related]  

  • 19. [COMBINED THERAPY OF DIABETES MELLITUS WITH SULFONAMIDES AND INSULIN].
    MORDKOVSKAIA NM
    Probl Endokrinol Gormonoter; 1964; 10():3-7. PubMed ID: 14259009
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the combined uses of hypoglycemic sulfonamides and procaine. Experimental study in rats].
    MAURI AC; CORBETT CE; SARAIVA PA
    Arq Bras Med; 1960; 50():117-24. PubMed ID: 13768433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.